Bharat Biotech to produce 80M monthly doses of Covaxin from December
19th October,2021 Mumbai
At present the company is producing 30-40 million per month
Hyderabad-based Bharat Biotech, the manufacturer of indigenous Covid-19 vaccine Covaxin, is aiming to produce 70-80 million doses monthly from December, lagging way behind the government's 400 million production estimate between August-December. At present the company is producing 30-40 million per month, a senior official told ET.
When we set out at the beginning of the year, we said that we want to be at an annualized rate of a billion doses a year, which means producing approximately 70-80 million doses monthly. That's the target for the end of the year. By December we aim to reach the monthly run rate of 70-80 million doses, added the official.
The company said that it has been increasing its capacity step by step from its facilities at Hyderabad, Bengaluru and Ankleshwar in Gujarat. We have currently passed the 30-40 million range and every month we will be adding 10-14 million doses